An 18 Percent Solution? Lilly And Daiichi Bet On A Premium Price For Effient Over Plavix
Wall Street analysts fret over a black box warning and see a slow uptake for Effient, but still expect drug to reach blockbuster status.
Wall Street analysts fret over a black box warning and see a slow uptake for Effient, but still expect drug to reach blockbuster status.